Evaluation of the Risk of Infection During Fever in Labor
NCT ID: NCT06517290
Last Updated: 2025-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
422 participants
OBSERVATIONAL
2024-08-08
2025-05-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* It has been the subject of several retrospective studies and a few prospective studies with varying methodologies, definitions, and inclusion criteria. None have proposed a combined obstetric, neonatal, infectious disease, and microbiological analysis.
* It raises concerns about the possibility of an emerging maternal (obstetric or otherwise) and/or fetal infection.
* Analysis of the available literature does not clarify the exact frequency of these infections or the predictive factors for their occurrence.
* It often justifies systemic antibiotic therapy, the modalities and benefits of which have never been evaluated.
The investigators aim to conduct a prospective multicenter study to analyze fever during labor with a combined obstetric, infectious disease, pediatric, and microbiological perspective.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia
NCT00326521
Does Maternal Fever During Labor Analgesia Has Any Relationship With Maternal Ventilation?
NCT02339389
Epidural Analgesia and Maternal Fever During Labor
NCT04940091
Perioperative Warming Measures in Cesarean Delivery
NCT05015582
Prevention of Maternal Hypothermia After Scheduled Caesarean Section Using Active Intravenous Warming
NCT03581721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Fever indicative of maternofetal infection: potentially early intrauterine infection leading to proven or probable early-onset neonatal bacterial infection, endometritis, or maternal sepsis.
2. Fever indicative of maternal infectious pathology outside the obstetrical field (e.g., pyelonephritis, influenza, COVID, etc.).
3. Fever of non-infectious origin.
Secondary objectives include:
* Describing the epidemiology and local ecology of bacterial infections.
* Identifying predictive factors for each category (obstetrical infection, non-obstetrical infection, and non-infectious fever) when fever occurs during labor.
* Evaluating the maternal and neonatal prognosis of mother-child pairs who do not receive antibiotic treatment according to local protocols (e.g., in cases of fever below a threshold value).
Depending on the results and sample size, the study will also attempt to evaluate the maternal and neonatal prognosis of mother-child pairs in cases where fever is attributed to maternofetal infectious causes (category 1) according to the antibiotic management strategy for fever during labor at each center.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fever during labor
Non applicable
Non applicable
Child
Non applicable
Non applicable
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non applicable
Non applicable
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Who have not opposed the collection of their health data for the purposes of studies and analyzes
* In work between 07/01/2023 and 06/01/2024
* Admitted to the work room at Port Royal, Necker Sick Children or Trousseau
* With fever defined as a tympanic temperature \> 38°C at least 2 times at 10 min intervals during labor.
Exclusion Criteria
* \< 37NT
* express their opposition to the collection of their data for research purposes
* minors or under legal protection
* context of medical termination of pregnancy or fetal death
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline CHARLIER, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Infectious diseases department of Cochin hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
APHP - Trousseau Hospital - Gynecology-Obstetrics-Maternity
Paris, IDF, France
AP-HP - Cochin Hospital - Maternity
Paris, IDF, France
APHP - Necker Hospital - Maternity
Paris, IDF, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP240875
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.